Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2022
|
Brendan R Oneill Director |
SELL
Open market or private sale
|
Direct |
6,520
-46.54%
|
$1,467,000
$225.5 P/Share
|
|
Nov 03
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Bona fide gift
|
Direct |
2,800
-3.86%
|
-
|
|
Nov 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.56%
|
$306,600
$219.07 P/Share
|
|
Oct 31
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,000
-7.93%
|
$436,000
$218.55 P/Share
|
|
Oct 04
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.54%
|
$294,000
$210.0 P/Share
|
|
Oct 01
2022
|
Paul C Reilly Director |
BUY
Grant, award, or other acquisition
|
Direct |
746
+50.0%
|
-
|
|
Sep 07
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
13,925
-3.45%
|
$2,882,475
$207.7 P/Share
|
|
Sep 07
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
13,925
+13.88%
|
$1,531,750
$110.58 P/Share
|
|
Sep 07
2022
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,030
-32.11%
|
$216,300
$210.26 P/Share
|
|
Sep 07
2022
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,758
-11.75%
|
$358,632
$204.92 P/Share
|
|
Sep 07
2022
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
64
+0.43%
|
-
|
|
Sep 02
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.51%
|
$294,000
$210.0 P/Share
|
|
Aug 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
10,000
-12.13%
|
$2,090,000
$209.47 P/Share
|
|
Aug 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.81%
|
$1,100,000
$110.58 P/Share
|
|
Aug 18
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
22,487
-23.68%
|
$4,947,140
$220.0 P/Share
|
|
Aug 18
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
22,487
+19.15%
|
$2,473,570
$110.58 P/Share
|
|
Aug 17
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
398
-0.55%
|
$87,560
$220.0 P/Share
|
|
Aug 17
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
398
+0.54%
|
$43,780
$110.58 P/Share
|
|
Aug 16
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
1,100
-1.5%
|
$242,000
$220.02 P/Share
|
|
Aug 16
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+1.47%
|
$121,000
$110.58 P/Share
|
|
Aug 09
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,129
-7.75%
|
$1,082,219
$211.71 P/Share
|
|
Aug 09
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,519
+8.97%
|
$717,090
$110.58 P/Share
|
|
Aug 08
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,940
-6.2%
|
$827,400
$210.67 P/Share
|
|
Aug 08
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.29%
|
$550,000
$110.58 P/Share
|
|
Aug 05
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-6.32%
|
$821,600
$208.78 P/Share
|
|
Aug 05
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.4%
|
$550,000
$110.58 P/Share
|
|
Aug 04
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.49%
|
$294,000
$210.01 P/Share
|
|
Aug 04
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,949
-6.42%
|
$821,392
$208.92 P/Share
|
|
Aug 04
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.52%
|
$550,000
$110.58 P/Share
|
|
Aug 03
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,964
-6.56%
|
$816,584
$206.33 P/Share
|
|
Aug 03
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.64%
|
$550,000
$110.58 P/Share
|
|
Aug 02
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,978
-6.69%
|
$811,512
$204.03 P/Share
|
|
Aug 02
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.76%
|
$550,000
$110.58 P/Share
|
|
Aug 01
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,973
-6.8%
|
$810,492
$204.78 P/Share
|
|
Aug 01
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.88%
|
$550,000
$110.58 P/Share
|
|
Jul 20
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
1,395
-1.89%
|
$276,210
$198.47 P/Share
|
|
Jul 20
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
34
+0.05%
|
-
|
|
Jul 20
2022
|
Anne Pullum Head of Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-9.41%
|
$271,458
$198.47 P/Share
|
|
Jul 20
2022
|
Anne Pullum Head of Europe |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
25
+0.17%
|
-
|
|
Jul 20
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,359
-4.23%
|
$467,082
$198.47 P/Share
|
|
Jul 20
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
34
+0.06%
|
-
|
|
Jul 20
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-1.55%
|
$293,634
$198.47 P/Share
|
|
Jul 20
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
34
+0.04%
|
-
|
|
Jul 20
2022
|
Adam Garrard Head of Risk & Broking |
SELL
Payment of exercise price or tax liability
|
Direct |
1,592
-11.33%
|
$315,216
$198.47 P/Share
|
|
Jul 20
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
25
+0.18%
|
-
|
|
Jul 20
2022
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,866
-6.97%
|
$369,468
$198.47 P/Share
|
|
Jul 20
2022
|
Matthew Furman General Counsel |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
26
+0.1%
|
-
|
|
Jul 20
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
713
-4.62%
|
$141,174
$198.47 P/Share
|
|
Jul 20
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
22
+0.14%
|
-
|
|
Jun 08
2022
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|